Ionis Pharmaceuticals revenue was $729.26 m in FY, 2020 which is a (35.0%) year over year decrease from the previous period.
Ionis Pharmaceuticals revenue breakdown by business segment: 80.4% from Ionis Core and 19.6% from Akcea Therapeutics
|FY, 2020||FY, 2019||FY, 2018|
|Ionis Core||$622.94 m||$858.65 m||$641.94 m|
|Akcea Therapeutics||$152.32 m||$488.54 m||$64.87 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.